Neoadjuvant Chemotherapy Linked to Lower Survival Than Adjuvant Therapy in Operable Breast Cancer
A multicenter retrospective study in China found that operable hormone receptor-positive, HER2-negative breast cancer was associated with shorter disease-free and ...










